20
2
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T83935 | eIF4A i28 | ||
eIF4A i28, an inhibitor of the eukaryotic initiation factor-4A (eIF4A) with an IC50 of 8.60 μM in an eIF4A ATPase assay, effectively reduces the viability of BJAB Burkitt lymphoma cells, as indicated by an EC50 of 0.46 μ... | |||
T39530 | eIF4A3-IN-5 | eIF4A3-IN-5 | |
eIF4A3-IN-5 is a highly effective inhibitor of eukaryotic initiation factor 4A (eIF4A), specifically targeting eIF4AI and eIF4AII. With its potent inhibitory properties, eIF4A3-IN-5 shows great potential for advancing re... | |||
T62884 | eIF4A3-IN-6 | ||
eIF4A3-IN-6 is a potent inhibitor of eukaryotic initiation factor 4A (eIF4A) (e.g. eIF4AI and eIF4AII). eIF4A3-IN-6 has the potential to be investigated in eIF4A-dependent diseases, including cancer. | |||
T62161 | eIF4A3-IN-4 | ||
eIF4A3-IN-4 is a novel inhibitor of eIF4A (IC50: 8.6 μM). | |||
T72943 | eIF4A3-IN-17 | ||
eIF4A3-IN-17, a silvestrol analogue, disrupts the assembly of the eIF4F translation complex, exhibiting EC50 values of 0.9, 15, and 1.8 nM for myc-LUC, tub-LUC, and growth inhibition of MBA-MB-231 cells, respectively. Th... | |||
T73001 | eIF4A3-IN-9 | ||
eIF4A3-IN-9, a silvestrol analogue, disrupts the assembly of the eIF4F translation complex, exhibiting EC50 values of 29, 450, and 80 nM for myc-LUC, tub-LUC, and growth inhibition in MBA-MB-231 cells, respectively. It i... | |||
T11170 | eIF4A3-IN-1 | Others | |
eIF4A3-IN-1 is a selective eukaryotic initiation factor 4A3 (eIF4A3) inhibitor (IC50=0.26 μM; Kd=0.043 μM), which binds to a non-ATP binding site of eIF4A3 and shows significant cellular nonsense-mediated RNA decay (NMD... | |||
T11171 | eIF4A3-IN-2 | Others | |
eIF4A3-IN-2 is a highly selective and noncompetitive eukaryotic initiation factor 4A-3 inhibitor with an IC50 of 110 nM. | |||
T72746 | (R)-eIF4A3-IN-2 | ||
(R)-eIF4A3-IN-2, a less active enantiomer of eIF4A3-IN-2, is a highly selective and noncompetitive inhibitor of the eukaryotic initiation factor 4A-3 (eIF4A3) with an IC50 of 110 nM. | |||
T39921 | eIF4A3-IN-7 | eIF4A3-IN-7 | |
eIF4A3-IN-7 is a highly effective inhibitor of eIF4A3, exhibiting significant potential for research in cancer and dysproliferative diseases. | |||
T72944 | eIF4A3-IN-18 | ||
eIF4A3-IN-18, a silvestrol analogue, disrupts the formation of the eIF4F translation complex, exhibiting EC 50 values of 0.8, 35, and 2 nM for myc-LUC, tub-LUC, and the growth inhibition of MBA-MB-231 cells, respectively... | |||
T22592 | ATPγS tetralithium salt | ATP-gamma-S tetralithium salt | PERK |
ATPγS tetralithium salt is a substrate for nucleotide hydrolysis and RNA unraveling activity of the eukaryotic translation initiation factor eIF4A, associated with p97 mutants and prions. | |||
T17296 | Zotatifin | eFT226 | Others |
Zotatifin is a potent and well-tolerated eIF4A inhibitor. Zotatifin promotes eIF4A binding to specific mRNA sequences with recognition motifs in the 5’-UTRs (IC50=2 nM). Zotatifin effectively reduces viral infectivity by... | |||
T10847 | CMLD012072 | Others | |
CMLD012072 is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor with potent anti-neoplastic activity. It can induce RNA clamping of eIF4A1 and eIF4A2. | |||
T27544 | Hippuristanol | ||
Hippuristanol is a potent steroid inhibitor of eukaryotic initiation factor 4A (eIF4A). | |||
T10848 | CMLD012073 | Others | |
CMLD012073 is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor. It inhibits NIH/3T3 cells (IC50: 10 nM). CMLD012073 inhibits eukaryotic translation initiation by modifying the behavior of the RNA helicase (eIF4... | |||
T38753 | CR-1-31-B | ||
CR-1-31-B, a synthetic rocaglate, acts as a highly potent inhibitor of eIF4A. By disrupting the interaction between eIF4A and RNA, it effectively obstructs the initiation phase of protein synthesis. Specifically, CR-1-31... | |||
T36750 | Didesmethylrocaglamide | ||
Didesmethylrocaglamide, a Rocaglamide derivative, is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor that exhibits strong growth-inhibitory effects, with an IC50 of 5 nM. It hinders several growth-promoting si... | |||
T10849 | CMLD012612 | Others | |
CMLD012612 is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor. It inhibits cell translation and is cytotoxic to NIH/3T3 cells (IC50: 2 nM). | |||
T71395 | Rohinitib | ||
Rohinitib, a potent and specific eIF4A inhibitor, effectively induces apoptosis in acute myeloid leukemia (AML) cell lines and decreases the leukemia burden in AML xenograft models. This compound is utilized in the resea... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TQ0131 | Rocaglamide | Rocaglamide A,Roc-A | HSP , NF-κB , PERK |
Rocaglamide (Roc-A), isolated from the genus Aglaia, can be used to treat coughs, injuries, asthma, and inflammatory skin diseases. It is a potent inhibitor of NF-κB activation in T-cells. | |||
T11215 | Episilvestrol | Others | |
Episilvestrol is a specific eIF4A-targeting translation inhibitor, with antitumor activity. Episilvestrol is a derivative of silvestrol, isolated from the fruits and twigs of Aglaia silvestris. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01306 | EIF4A1 Protein, Human, Recombinant (His & Myc) | Human | E. coli |
ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary str... | |||
TMPH-01307 | EIF4A2 Protein, Human, Recombinant (GST) | Human | E. coli |
EIF4A2 Protein, Human, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 73.4 kDa and the accession number is Q14240. | |||
TMPJ-00507 | EIF4E Protein, Human, Recombinant | Human | E. coli |
Eukaryotic translation initiation factor 4E is a 217 amino acids protein that belongs to the eukaryotic initiation factor 4E family. eIF4F is a multi-subunit complex, the composition of which varies with external and int... |